A long term follow up study of ATX-101 given by intravenous infusion once every week in patients with advanced solid tumours
ACTRN 12618001112257 Brief Summary This is a Phase I, open-label, single arm,…
Read more arrow_forwardACTRN 12618001112257 Brief Summary This is a Phase I, open-label, single arm,…
Read more arrow_forwardACTRN 12618001070224 Brief Summary This is a Phase I, open-label, single arm,…
Read more arrow_forwardACTRN 12620000592943 Brief Summary This purpose of this study is to determine…
Read more arrow_forwardACTRN 12618001074280 Brief Summary This study’s purpose is to facilitate and expedite…
Read more arrow_forwardNCT 06179160 Brief Summary This study is conducted to determine the safety…
Read more arrow_forwardNCT 06710847 Brief Summary Solid tumours are abnormal lumps of tissue that…
Read more arrow_forwardNCT 02582697 Brief Summary The purpose of this study is to determine…
Read more arrow_forwardNCT 03067181 Brief Summary This phase III trial studies how well active…
Read more arrow_forwardACTRN 12620000583943 Brief Summary The purpose of this study is to examine…
Read more arrow_forward